Individuals with intellectual and developmental disability (IDD) can have a high prevalence of pain, which can be managed with prescription opioids. However, the prevalence of substance use disorder is also high in this population, raising concern about opioid-related adverse events.
This study assessed the risk of opioid-related adverse events following opioid initiation among adults with versus without IDD.
Access the full article and associated resources: